The BMJ has an evidence-based look at whether other countries that pay less for drugs are free-riding on research paid for by US consumers:
Worth a look.
In a tight race, one of pharma’s favorite senators gets a little help from his friends - The North Carolina senator has been a staunch ally for drug companies. Now, facing a strong challenge, the industry is returning the favor.
1 hour ago